What is Dogwood Therapeutics's EBITDA?

Dogwood Therapeutics (DWTX) reported EBITDA of -$3.91M in Q2 2025.

How has Dogwood Therapeutics's EBITDA changed year-over-year?

Dogwood Therapeutics's EBITDA decreased by 266.1% year-over-year, from -$1.07M to -$3.91M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

Dogwood Therapeutics DWTX EBITDA

EBITDA at other companies

Collegium Pharmaceutical, Inc.COLL

$86.83M+11.0%

BioventusBVS

$19.62M+17.3%

Avanos MedicalAVNS

$19.1M-4.0%

Eli LillyLLY

——

PfizerPFE

——

Vertex PharmaceuticalsVRTX

——

Other financials

Income statement

See full

Operating income-$5.1M-14.6%

Net income-$5.0M+54.4%

EPS (diluted)-$0.15+98.2%

Balance sheet

See full

Cash & equivalents$13.2M-24.6%

Total debt$144.9K-24.2%

Total equity$80.6M+1,038%

Total assets$95.2M-1.8%

Cash flow

See full

Operating cash flow-$4.6M+2.0%

Valuation

See full

Market cap$54.14M-57.6%

Enterprise value$41.06M-64.7%

Returns & leverage

See full

Return on equity-64.6%-29.8pp

Debt / equity0×0.0×

Current ratio5.9×-1.6×

Where this comes from

Calculated from Dogwood Therapeutics’s reported figures.

−$3.9Mebit+

$17.3KDepreciation Depletion & Amortization

=-$3.91M

The official record: Dogwood Therapeutics’s 10-Q, filed August 13, 2025, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Dogwood Therapeutics's EBITDA?: Dogwood Therapeutics (DWTX) reported EBITDA of -$3.91M in Q2 2025.
How has Dogwood Therapeutics's EBITDA changed year-over-year?: Dogwood Therapeutics's EBITDA decreased by 266.1% year-over-year, from -$1.07M to -$3.91M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.